India to France: Hydrochlorothiazide Export Trade Route

The India to France Hydrochlorothiazide corridor is one of India's established pharmaceutical export routes, with 557 shipments documented worth a combined $17.1M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 60% of all export value, reflecting the consolidated nature of India's hydrochlorothiazide manufacturing sector.

Across 23 active suppliers, the average shipment value stands at $30.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with hydrochlorothiazide's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 15.5%, placing it at rank #4 among India's top hydrochlorothiazide export destinations globally.

On the import side, key buyers of Indian hydrochlorothiazide in France include CSP VIATRIS SANTE AT CSP- LAB,, ARROW GENERIQUES,, CSP VIATRIS SANTE AT CSP LAB and 45 others. CSP VIATRIS SANTE AT CSP- LAB, is the single largest importer with 37 shipments valued at $5.8M USD.

India's hydrochlorothiazide exports to France are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 121 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 23 active exporters signals a competitive but concentrated market — buyers in France benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MYLAN LABORATORIES LIMITED, AUROBINDO PHARMA LTD, MYLAN LABORATORIES LIMITED — together account for 75% of total trade value on this route. The average shipment value of $30.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as irbesartan / hydrochlorothiazide mylan 3 and irbesartan / hydrochlorothiazide mylan 3 , suggesting that buyers in France tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, CSP VIATRIS SANTE AT CSP- LAB, is the largest importer with 37 shipments worth $5.8M USD — representing 34% of all hydrochlorothiazide imports from India on this route. A total of 48 buyers are active on this corridor.